Medical Properties Trust - Third Quarter 2026 Earnings Call - MEDICAL PROPERTIES TRUST INC

Explicit Guidance:

• Revenue & Cash Flow: Management expects portfolio cash rent to remain above $1 billion annually for the full year 2027, despite recent property sales; no specific revenue guidance provided for subsequent years.
• Rent Payments (HSA): No projected date for the resumption of full rent collections from the HSA (now Ardonis) portfolio; current status is that cash collections increased 24% since August due to new management, but a timeline for rent recovery remains undefined.
• Rent Payments (NOR): NOR is scheduled to transition from paying 50% to 100% of contractual rent in December 2026.
• Capex & Asset Sales: No formal capex guidance; however, the NOR development budget increase is attributed to a new ED project and seismic work, while HSA budget increases cover replacements (elevators, boilers, roofs) and a parking garage at Hialeah.
• Dividends: Management indicated no specific plans or timeline for dividend initiation, citing the need to continue balance sheet restructuring and address HSA operations first.
• Balance Sheet Maturities: Targeting a debt maturity profile with no maturities until June 2028; current $665 million in 2027 notes and $200 million term loan (due June 2027) are targeted for refinancing or repayment via Step 2 financing.

Business-Segment Outlook:

• HSA (Ardonis): Revenue cycle management (RCM) challenges persist; Ovation Healthcare (Nashville-based, managing 500+ hospitals) has taken over all operations immediately to fix billing/RCM. Volume is up 14% (surgeries up 33%); new payer agreements with Miami's largest HMO and CMS residency programs at St. Joseph (Houston) and Hialeah (starting 2027) expected to drive volume and reimbursement.
• UK (Priory): Lease modified to reduce annual rental obligations by ~18% with a variable rent component triggered if revenue hurdles are met; lease term extended by 10 years at MPT's election, with extension option allowing lease to run until 2055.
• Post-Acute Care: Identified as a "clear portfolio differentiator" with improving coverage and demand; Earnest Health maintains 2.5x coverage; NOR maintains 2.4x coverage with full contractual rent expected by year-end.
• Behavioral Health: Early signs of stabilization in Europe; operators targeting staffing and service mix improvements.
• Swiss Medical Network / IMED (Spain): Swiss Medical showing >2x coverage driven by integrated care networks; IMED surgeries up >11% YoY, led by 40% increase at IMED Valencia; new facilities in Alicante and Barcelona opening in the "coming months" to expand capacity.
• Colombia: Impairment charges recorded due to August earthquake; management cites recent positive discussions with the government and remains "encouraged about the direction and future" of facilities.

Market and Competitive Outlook:

• Demand Trends: Strong global demand for healthcare services; U.S. post-acute sector showing "meaningful momentum."
• Pricing/Revenue: Ability to recover foregone rent at Priory as patient volumes/revenue recover; variable rent structure implemented to capture upside.
• Supply/Capacity: Expansion at IMED (Alicante, Barcelona) and NOR (new ED) expected to absorb demand; HSA volume growth driven by increased referrals and residency programs.
• Competitive Position: MPT emphasizes portfolio diversity (50+ operators) and strong coverage metrics (median delivered, NOR, Earnest) as competitive moats against operator distress.

Macro / Industry Outlook:

• UK Macro: NHS budget constraints continue to limit funding for behavioral health demand; management views current rent reduction as a reaction to this structural government constraint rather than operator failure.
• U.S. Macro: Interest rate environment managed via debt refinancing and covenant optimization; MPT views current market conditions as conducive to asset monetization (transacting at sub-7% cap rates).
• Regulatory: CMS reimbursement expected to increase for HSA due to new residency programs; no major regulatory shifts anticipated that would negatively impact the broader model.

Strategic Initiatives:

• Debt Refinancing (Step 2): Plans to extend multi-year bank revolver, repay $200 million term loan (June 2027), and refinance $665 million 2027 notes; new revolver expected to eliminate secured leverage covenants and provide headroom up to 225% unencumbered asset coverage by year-end.
• Lease Restructuring: Completed agreement with Priory to reduce rent by 18%, add variable rent component, and extend lease term by 10 years (up to 2055).
• M&A/Asset Monetization: $600 million proceeds from Q2 asset sales; $370 million from Q3 sale of Idaho facilities; $170 million from minority JV interest sale. No meaningful assets currently pending for sale, but optionality remains for future transactions.
• Management Change: HSA operations transferred to Ovation Healthcare to address RCM failures; Priory lease terms improved to enhance parent company credit profile.

Risks and Headwinds to Outlook:

• HSA Collection Risk: Continued inability of HSA/Ardonis to collect from payers could delay rent resumption indefinitely; management acknowledges "Plan B" (changing operators) is an option if operations decline, though currently not anticipated.
• UK Budget Constraints: Continued NHS underfunding could limit Priory's revenue recovery and ability to trigger variable rent clauses.
• Geopolitical/Disaster Risk: Prior earthquake in Colombia caused impairment; future disaster risk remains a consideration.
• Refinancing Execution: Step 2 refinancing (revolver extension and note replacement) is ongoing; failure to secure favorable terms or timing could impact liquidity.
• Capex Overruns: NOR and HSA development budgets increased due to project scope changes and seismic work; further increases possible.

Management Tone on the Future:

• Confidence: High confidence in the long-term business model and portfolio diversification; "optimistic" regarding Ovation's ability to fix HSA; "encouraged" by stabilization in behavioral health.
• Balance Sheet Health: Describes balance sheet as "meaningfully strengthened" with substantial headroom in covenants; views asset sales as a source of flexibility rather than a necessity.
• Hedging: Avoids specific future date projections for HSA rent; hedges UK rent expectations with variable components tied to revenue recovery.

Miscellaneous:

• Accounting: $70 million gain recognized from debt extinguishment discount; $24 million impairment charge in Colombia; $158 million gains on asset sales in Q3.
• Collateral: Loan to HSA stands at $150 million.
• Valuation: Historical hospital real estate sales (since 2022) realized ~23% increase over original undepreciated book values; current unencumbered asset ratio >180%, potentially rising to 225%.